The Chemours, Intel, BP, and Others

Welcome to Extreme Investor Network, where we provide you with exclusive insights on the latest news and trends in the world of finance. Today, we’re diving into the companies making headlines before the bell:

Chemours – This chemical company is seeing a 3% increase after UBS upgraded it to buy from neutral. UBS predicts that the stock could outperform as refrigerants experience favorable demand and price drivers heading into next year.

Nvidia – Shares of this chipmaker rose over 1% after KeyBanc raised its price target to $180, suggesting a 40% upside from Monday’s close. Despite the impending launch of Blackwell in 2H24, KeyBanc remains optimistic about Nvidia’s performance, citing robust demand for H100.

Related:  Morning Brief: The market should not celebrate a larger rate cut in September

BP – The oil and gas giant’s U.S.-listed shares dropped by more than 4% after the company warned of an impairment of up to $2 billion. Additionally, BP anticipates weak margins from its refining business.

Tempus AI – This health-care diagnostics company saw a nearly 4% increase in shares after receiving buy or overweight ratings from several Wall Street banks. Using artificial intelligence to interpret medical tests, Tempus AI made its debut on the Nasdaq in June.

Intel – The chipmaker experienced a 2.7% rise in early morning trading, continuing its comeback for the week with a 6.1% increase in shares.

Helen of Troy – Shares of this parent company of Hydro Flask and Oxo dropped over 25% following a significant earnings miss. While the company earned 99 cents per share, excluding items, analysts had expected a profit of $1.59 per share. Quarterly revenue guidance also fell below estimates.

Related:  How Low Will Bond Spreads Sink? Five Key Metrics to Monitor

At Extreme Investor Network, we provide in-depth analysis and expert opinions to keep you informed and ahead of the curve in the world of finance. Stay tuned for more exclusive content and unique insights that you won’t find anywhere else.

Source link